Overview of Lastin
| Property | Description |
|---|---|
| Active ingredient | Azelastine hydrochloride |
| Form | Aqueous solution (Nasal spray, eye drops) |
| Pharmacological class | Second-generation antihistamine, Dual-acting antiallergic agent |
| Common use | Relieving symptoms of allergic rhinitis and conjunctivitis |
| Origin | Synthetic (Phthalazinone derivative) |
Lastin is a medicinal product distinguished by its active compound, Azelastine hydrochloride, a synthetic chemical entity clinically recognized for its anti-allergic capabilities. Pharmacologically, it is classified as a second-generation antihistamine and a dual-acting antiallergic agent. This classification reflects its specialized mechanism; as a phthalazinone derivative, Azelastine is engineered to exhibit selective histamine H1-receptor antagonist activity. This dual functionality has been the focus of pharmacological studies, confirming its ability to address both immediate histamine response and subsequent inflammatory processes.
Composition and Form: Lastin as a Localized Solution
The formulation of Lastin utilizes Azelastine hydrochloride dissolved in an aqueous vehicle, a water-based solution, which is key to its targeted application. It is primarily delivered through a metered-dose nasal spray for intranasal use or an ophthalmic solution (eye drops) for ocular application. These forms are established for localized topical administration, confirming the suitability of the compound for this route. This mode of delivery provides rapid action at the primary site of allergic irritation. As a differentiating factor, Lastin's nasal spray is typically positioned for managing both seasonal and year-round allergic rhinitis symptoms, often targeting patient groups seeking relief from persistent, perennial issues.
Primary Action and General Purpose
The general purpose of Lastin is to quickly alleviate the allergic response and subsequent symptoms in the eyes and nose. It achieves this through its dual mechanism principle: it immediately blocks histamine receptors, preventing the effects of histamine release, and simultaneously acts as a mast cell stabilizer, inhibiting the release of key inflammatory mediators. The compound's dual ability to antagonize H1-receptors and inhibit mediator release is a key characteristic of its pharmacological profile. The drug's therapeutic focus is on quickly mitigating common allergy-related discomforts, such as nasal itching and congestion or ocular irritation, making it suitable for a scenario where a patient requires targeted relief from environmental allergens.
